LG-2293

N/A

Report date: 2023/05/17 08:52:00

Base Information

Drug NameLG-2293
Drug Alias NameLG-121100
ClassificationSmall molecules
Mechanisms of ActionTestosterone congeners inhibitorsAndrogen Receptor antagonists
TargetsTestosterone congenersAndrogen Receptor
Therapy Area/IndicationsSkin DiseasesProstatic HyperplasiaProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLigand Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSkin DiseasesProstatic HyperplasiaProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A